在部分观察到的生物分子网络中,用于因果查询估计的最佳调整集
Sara Mohammad-Taheri1, Vartika Tewari1, Rohan Kapre1
1Khoury College of Computer Sciences, Northeastern University, Boston, MA 02115, USA.
Bioinformatics (Oxford, England)
|June 30, 2023
概括
本研究介绍了生物分子网络中因果推理的最佳调整集,通过考虑数据生成过程来改进基于图形的方法. 这使得干预效应的估计更加准确,特别是在部分观察到的网络中.
科学领域:
- 生物分子网络是生物分子网络.
- 因果推断的原因推断是因果推断.
- 系统生物学 系统生物学
背景情况:
- 在生物分子网络中因果查询估计依赖于有效的调整集以消除估计器偏差.
- 可以存在多个有效的调整集,它们在变异方面存在差异,影响估计准确性.
- 目前的基于图形的方法在部分观察到的网络中选择调整集,最大限度地减少了非对称差异,但忽视了数据生成过程.
研究的目的:
- 在生物分子网络中开发一种新的方法来导出"最佳调整集".
- 为了解决基于拓学的标准的局限性,当数据生成过程不同时无法区分差异.
- 提高因果效应估计和干预特征的准确性.
主要方法:
- 经验学习数据从历史实验数据生成过程.
- 通过模拟来表征估计器属性,包括偏差和有限样本方差.
- 开发一种考虑数据特征,估计器属性和成本的方法.
主要成果:
- 在四个不同的生物分子案例研究中证明了拟议方法的实用性.
- 通过考虑数据生成的具体情况,展示了改进的调整集选择.
- 为更广泛的采用提供了实施和可重复的案例研究.
结论:
- 提出的用于导出最佳调整集的方法增强了生物分子网络中的因果推理.
- 对数据生成过程的核算可以使干预效应的估计更加稳健和准确.
- 这种方法比现有的基于图表的方法提供了显著的改进,特别是在复杂的,部分观察到的生物系统中.
相关概念视频
02:26Protein Networks
4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
02:18The Equilibrium Binding Constant and Binding Strength
13.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.0K
00:49Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
02:04Covalently Linked Protein Regulators
6.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.9K
02:04Protein-protein Interfaces
12.6K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.6K
01:24One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
582
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
582